What score on the Patient Health Questionnaire-9 (PHQ-9) indicates a positive depression screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PHQ-9 Positive Depression Screening Threshold

A PHQ-9 score of 8 or higher indicates a positive depression screening and warrants clinical intervention. 1, 2

Evidence-Based Cutoff Score

The American Society of Clinical Oncology guideline specifically recommends a cutoff score of 8 rather than the traditional cutoff of 10, based on diagnostic accuracy studies in cancer outpatients and supported by meta-analysis data. 1, 2 This lower threshold improves sensitivity for detecting clinically significant depression while maintaining acceptable specificity. 1

Phased Screening Approach

Initial Two-Item Screen:

  • Begin with the first two PHQ-9 items assessing anhedonia ("Little interest or pleasure in doing things") and depressed mood ("Feeling down, depressed, or helpless"). 1, 2
  • If either item scores 2 or higher (occurring "more than half the days" or "nearly every day"), complete the full 9-item PHQ-9. 1
  • If both items score 0-1, no further screening is needed. 1, 2

This phased approach reduces burden, as only 25-30% of patients require completion of the full questionnaire. 1

Score Interpretation and Clinical Action

Score 1-7 (Minimal/Mild):

  • No or minimal symptoms of depression 1, 2
  • Effective coping skills and social support typically present 1, 2
  • No formal treatment required, but provide patient education and schedule reassessment 2, 3

Score 8-14 (Moderate):

  • Subthreshold depressive symptoms with mild to moderate functional impairment 1, 2
  • Seek consultation with psychology or psychiatry for diagnostic confirmation 1
  • Consider low-intensity interventions: guided self-help based on cognitive behavioral therapy, structured physical activity programs, or pharmacologic treatment 2, 4

Score 15-19 (Moderately Severe):

  • Most depressive symptoms present with moderate to marked functional interference 1, 2
  • Mandatory referral to psychology and/or psychiatry for diagnosis and treatment 1, 2

Score 20-27 (Severe):

  • Severe symptomatology with significant functional impairment 1, 2
  • Immediate referral to psychology and/or psychiatry required 1, 2

Critical Safety Assessment

Never omit Item 9 regarding self-harm thoughts ("Thoughts that you would be better off dead or hurting yourself in some way"). 1, 2

  • If any self-harm ideation is endorsed at any frequency, immediate referral for emergency psychiatric evaluation is mandatory regardless of total PHQ-9 score. 1, 2, 3
  • Facilitate a safe environment and one-to-one observation if self-harm risk is present. 1, 2
  • Omitting this item artificially lowers scores and misses critical risk information, weakening the predictive validity of the assessment. 1, 2

Common Pitfalls to Avoid

  • Do not use the traditional cutoff of 10—the evidence-based threshold of 8 detects more cases of clinically significant depression. 1, 2
  • Do not fail to complete the full PHQ-9 if either of the first two items scores ≥2. 1, 2
  • Do not underestimate scores in the 8-14 range—these represent clinically significant depression requiring active intervention, not just watchful waiting. 2, 4
  • Do not omit the self-harm assessment even with low total scores, as patients can have minimal overall symptoms but still endorse suicidal ideation. 1, 2, 3

Special Considerations

  • Use culturally sensitive assessments when possible and tailor evaluation for patients with learning disabilities or cognitive impairments. 1, 2
  • The PHQ-9 loses accuracy in patients with significant cognitive impairment; consider alternative assessment methods in this population. 2
  • Assess associated sociodemographic factors, psychiatric or health comorbidities, social impairments, and duration of depressive symptoms when interpreting scores. 1, 2

Screening Timing

Administer the PHQ-9 at:

  • Initial diagnosis or start of treatment 1, 2
  • Regular intervals during treatment 1, 2
  • 3,6, and 12 months after treatment completion 1, 2
  • Diagnosis of recurrence or progression 1
  • Times of personal transition, family crisis, or changes in health status 1, 2
  • When approaching end of life in palliative care settings 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Significance of PHQ-9 Score for Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Mild Depressive Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Approach for Moderate Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.